ORMP — ORAMED PHARMACEUTICALS INC (Healthcare >> Biotechnology)
ORMP FAQ
What is ORMP's P/E ratio?
ORAMED PHARMACEUTICALS INC (ORMP) currently trades at a P/E ratio of 1.34.
What is ORMP's ROE?
ORAMED PHARMACEUTICALS INC reports a Return on Equity (ROE) of 46.17%.
What is ORMP's dividend yield?
ORAMED PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is ORMP's Deepscope Quality Score?
Deepscope rates ORMP's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ORMP?
Deepscope's AI Timing Score for ORMP is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ORMP belong to?
ORAMED PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.60
Price
0.05
(1.39%)
Day Change
|
|
|---|
ORMP Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Khá , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
67% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
24
GREAT
|
| Magic Formula Rank by ROE |
24
GREAT
|
| Magic Formula Rank by ROIC |
42
GREAT
|
| Price | 3.60 |
| PBV / Sector |
0.62 / 4.53
GREAT
|
| Earning Per Share | 2.69 |
| PE / Sector |
1.34 / 16.80
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.51
|
| Average 1M Daily Value |
0.96 M
GREAT
|
| Average 1W Daily Value |
1.04 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-03 09:10:53 |
| Symbol | ORMP |
| Name | ORAMED PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 40.93 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 147.33 / 8,614.17 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
Phone: 844 967 2633
Website: https://oramed.com
Sector: Healthcare >> Biotechnology
Description: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google